Enable job alerts via email!
Boost your interview chances
A leading clinical-stage oncology company is seeking a Scientist III/Senior Scientist, Group Leader to lead drug discovery projects. The role involves mentoring junior scientists and conducting experiments to design biologic screening assays. The ideal candidate will have a Ph.D., experience in oncology research, and a strong background in drug development.
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes but is not limited to: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. To support execution for these programs, Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radioconjugate manufacturing facility to meet supply demand for our growing pipeline of RCs.
The Role: The Scientist III/Senior Scientist, Group Leader is expected to lead the scientific execution of drug discovery projects in alignment with departmental goals and timelines by designing and conducting experiments, setting objectives, delivering on project milestones, along with analyzing, interpreting and communicating results according to timelines.
Responsibilities